Enlicitide（MK-0616)

Cas：2407527-16-4
Enlicitide (MK‑0616, LIPFENDRA®) is an oral once-daily macrocyclic PCSK9 inhibitor peptide for lowering LDL‑C in patients with hypercholesterolemia.